论文部分内容阅读
我院5年来用蝮蛇抗栓酶治疗60例突聋患者,有明显疗效,报道如下。对象和方法 本文将1986年8月至1991年6月住院突聋病人118例,随机抽样分成两组。抗栓酶组60例(60耳),男32例,女28例,年龄19～70岁,平均43岁。22例伴有眩晕,55侧耳鸣;11例有高血压病、动脉硬化;10例伴有发热、感冒史或病毒抗体滴度增高;24例有劳累或情绪波动史。10例前庭功能减退。23例未发现任何诱因.对照组为用扩血管剂组58例(58耳),男25例,女33例,平均年龄40.2岁。27例伴眩晕,48例有耳鸣;8例伴高血压病,动脉硬化;9例有发热,感冒或病毒抗体滴度增高;22例有劳累或情绪波动史。前庭功能减退8例,20例未发现任何诱因。
5 years in our hospital with viper antithrombin enzyme treatment of 60 patients with sudden deafness, a significant effect, reported as follows. Subjects and methods In this paper, from August 1986 to June 1991 hospitalized sudden deafness in 118 cases, randomly divided into two groups. Antithrombotic group of 60 cases (60 ears), 32 males and 28 females, aged 19 to 70 years, mean 43 years. 22 cases with dizziness, 55 side tinnitus; 11 cases of hypertension, atherosclerosis; 10 cases associated with fever, cold history or increased antibody titer; 24 cases of fatigue or mood swings. 10 cases of vestibular dysfunction. 23 cases did not find any incentive.The control group was vasodilator 58 cases (58 ears), 25 males and 33 females, with an average age of 40.2 years. 27 cases with vertigo, 48 cases of tinnitus; 8 cases with hypertension, atherosclerosis; 9 cases of fever, cold or virus antibody titers increased; 22 cases of fatigue or mood swings. Vestibular dysfunction in 8 cases, 20 cases did not find any incentive.